Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Profound Medical Corp
(TSX:
PRN
)
8.890
-0.460 (-4.92%)
Streaming Delayed Price
Updated: 1:56 PM EDT, Jun 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Profound Medical Corp
< Previous
1
2
3
4
Next >
Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone
October 16, 2025
Clinical validation from the Busch Center highlights the proven, scalable innovation driving a paradigm shift in prostate care — delivering precision treatment and better patient outcomes
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the Stifel 2025 Healthcare Conference
October 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
October 07, 2025
To release full third quarter 2025 financial results on November 13th; conference call to follow
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
August 28, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Second Quarter 2025 Financial Results
August 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
September 23, 2025
New program delivers TULSA Procedure’s precision treatment - minimal side effects, no overnight hospital stay – to Medicare patients across Texas
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
July 24, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
June 10, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
June 04, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
May 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces First Quarter 2025 Financial Results
May 08, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
April 30, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
April 29, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
April 17, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical AUA 2025 Investor Event Agenda
April 15, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Save the Date: Profound Medical to Host Investor Event at AUA 2025
March 25, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results
March 06, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
February 13, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
January 13, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
January 08, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares
December 10, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares
December 06, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Proposed Public Offering of Common Shares
December 05, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy
December 02, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’
November 26, 2024
TULSA procedure’s unrivaled flexibility, real-world efficacy and ongoing CAPTAIN post-market study to be featured in the scientific programs at the upcoming RSNA and SUO meetings
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the Stifel 2024 Healthcare Conference
November 12, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Third Quarter 2024 Financial Results
November 07, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
November 04, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow
October 17, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
